Predictors of influenza vaccine acceptance among healthy adults

Predictors of influenza vaccine acceptance among healthy adults
复制标题

DOI:
10.1006/pmed.1999.0535
复制
发表时间:
1999-10-01
影响因子:
5.1
通讯作者:
Coups, EJ
Coups, EJ
中科院分区:
医学2区
文献类型:
--
作者:
Chapman, GB;Coups, EJ

文献摘要

被引文献

相似文献

背景以前调查流感疫苗接受性预测因子的研究集中在高危患者或卫生保健工作者身上。很少有研究调查健康成年人在工作场所接受流感疫苗注射的情况,即使流感疫苗也推荐给这一群体。两项研究调查了健康成年人工作场所样本中流感疫苗接受度的预测因素。在第一项研究中,79名大学员工接受了采访,而在第二项研究中,435名公司员工完成了一份问卷。在第一项研究中,流感疫苗的接受程度是通过疫苗的有效性(r = 0.36)、疫苗副作用的可能性(r = -0.32)和前一年接种疫苗(r = 0.25)来预测的。在第二项研究中,流感疫苗的接受度再次被感知的有效性(r = 0.49),副作用的可能性(r = -0.31)和先前的流感疫苗(r = 0.66)预测,并且还与年龄(r = 0.10)和预测的同事谁也接受了注射(r = 0.24)的百分比有关。目前的研究表明,健康成年人接受疫苗的预测因素与高危患者人群和医护人员研究中确定的预测因素相似,(C)1999年美国健康基金会和学术出版社。
Background. previous studies investigating predictors of influenza vaccine acceptance have focused on high-risk patients or health care workers. Few studies have examined flu shot acceptance among healthy adults in workplace settings, even though influenza vaccine is recommended for this group as well.Methods. Two studies investigated predictors of flu vaccine acceptance in workplace samples of healthy adults. In the first study, 79 university employees were interviewed, while in the second, 435 corporate employees completed a questionnaire.Results. In the first study, flu shot acceptance was predicted by perceived effectiveness of the vaccine (r = 0.36), perceived likelihood of vaccine side effects (r = -0.32), and having received the shot in the previous year (r = 0.25). In the second study, flu shot acceptance was again predicted by perceived effectiveness (r = 0.49), likelihood of side effects (r = -0.31), and previous flu shot (r = 0.66) and was also related to older age (r = 0.10) and to predicted percentage of co-workers who also received the shot (r = 0.24).Conclusions. The current studies indicate that predictors of vaccine acceptance among healthy adults are similar to those identified in studies of high-risk patient populations and health care workers, (C) 1999 American Health Foundation and Academic Press.